The 53 references in paper Natalia Smirnova N, Natalja Kuprienko B., Наталия Смирнова Николаевна, Наталья Куприенко Борисовна (2016) “Инсулинорезистентность и нефропатия при ожирении у детей // Insulin resistance and nephropathy in obese children” / spz:neicon:nefr:y:2016:i:3:p:28-34

1
Hedley A, Ogden CL, Johnson CL et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 2004; 291:2847– 2850
(check this in PDF content)
2
Weedon MN. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316:889–894
(check this in PDF content)
3
Sofia Inez et al. Obesity Facts 2008;1:138–145 Published online: June 20, 2008 DOI: 10.1159/000137665
(check this in PDF content)
4
Adelman RD, Restaino JG, Alon US, Blowley DL Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 2001; 138:482–485
(check this in PDF content)
5
Royer P, Habib R, Mathieu H, Coutecuisse V. L’hypolasie rénale bilaterale congénitale avec réduction du nombre et hypertrophie des néphrons chez l’enfant. Annales de Pédiatrie 1962;9:133-140
(check this in PDF content)
6
Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974; 81: 440-447
(check this in PDF content)
7
Cohen AH. Massive obesity and the kidney. Am J Pathol1975; 81:17-130
(check this in PDF content)
8
D’Agati V. The many masks of focal segmental glomerulosclerosis. Kidney Int 1994; 46:1223-1241
(check this in PDF content)
9
Adelman RD, Restaino JG, Alon US, Blowley DL. Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents. J Pediatr 2001; 138:482-485
(check this in PDF content)
10
Kambham N, Markowitz GS, Valeri AM et al. Obesityrelated glomerulopathy: an emerging epidemic. Kidney Int 2001; 59:1498-1509
(check this in PDF content)
11
Schwimmer JA, Markowitz GS, Valeri AM et al. Secondary focal segmental glomerulosclerosis in non-obese patients with increased muscle mass. Clin Nephrol 2003; 60(4):233-241
(check this in PDF content)
12
Tomaszewski M, Charchar FJ, Maric C et al. Glomerular hyper filtration: a marker of metabolic risk. Kidney Int 2007; 71:816–821
(check this in PDF content)
13
Смирнов АВ, Румянцев АШ, Добронравов ВА, Каюков ИГ. XXI век – время интегративной нефрологии. Нефрология 2015; 19(2): 26-31 [Smirnov AV, Rumyantsev ASh, Dobronravov VA, Kayukov IG. XXI century – the time of integrative nephrology. Nephrology 2015; 19(2): 26-31]
(check this in PDF content)
14
Vikse BE, Irgens LM, Leivestad T et al. Low birth weight increases risk for end stage renal disease. J Am Soc Nephrol 2008; 19:151–157
(check this in PDF content)
15
Hovi P, Andersson S, Raikkonen K et al. Ambulatory blood pressure in young adults with very low birth weight. J Pediatr 2010; 156: 54–59
(check this in PDF content)
16
Phillips DI. Insulin resistance as a programmed response to fetal undernutrition. Diabetologia 1996; 39: 1119–1122
(check this in PDF content)
17
Gluckman P, Hanson M (eds). The Fetal Matrix: Evolution, Development and Disease. Cambridge: Cambridge University Press, 2005
(check this in PDF content)
18
Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res 2004; 56: 311–317
(check this in PDF content)
19
Hattersley AT, Tooke JE. The fetal insulin hypothesis: an alternative explanation of the association of low birth weight with diabetes and vascular disease. Lancet 1999; 353: 1789–1792
(check this in PDF content)
20
Day IN, Chen XH, Gaunt TR et al. Late life metabolic syndrome, early growth, and common polymorphism in the growth hormone and placental lactogen gene cluster. J Clin Endocrinol Metab 2004; 89: 5569–5576
(check this in PDF content)
21
Brenner BM, Lawler EV, Mackenzie HS. The hyper filtration theory: a paradigm shift in nephrology. Kidney Int 1996; 49: 1774–1777
(check this in PDF content)
22
Ingelfinger JR. Pathogenesis of perinatal programming. Curr Opin Nephrol Hypertens 2004; 13:459–464
(check this in PDF content)
23
Leeson CP, Kattenhorn M, Morley R et al. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 2001; 103:1264–1268
(check this in PDF content)
24
Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008; 5: 78-84
(check this in PDF content)
25
Juul A, Scheike T, Davidsen M et al. Low serum insulinlike growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002; 106:939–944
(check this in PDF content)
26
Johnston LB, Dahlgren J, Leger J et al. Association between insulin-like growth factor I (IGF-I) polymorphisms, circulating IGF-I, and pre- and postnatal growth in two European small for gestational age populations. J Clin Endocrinol Metab 2003; 88:4805–4810
(check this in PDF content)
27
Ricardo Sesso, Maria C.P. Franco. Abnormalities in Metalloproteinase Pathways and IGF-I Axis: A Link between Birth Weight, Hypertension, and Vascular Damage in Childhood. American journal of hypertension 2010; 23 (1): 6-11
(check this in PDF content)
28
Carolyn L. Abitbol; Maria M. Rodríguez. Obesity-Related Nephropathy in Children. Pediatr Health 2009; 3(2):141-153
(check this in PDF content)
29
Carolyn LA, Chandar J, Rodríguez MM et al. Obesity and preterm birth: additive risks in the progression of kidney disease in children. Pediatr Nephrol 2010; 23(3):413-419
(check this in PDF content)
30
Kursawe R. Metabolic Syndrome in Pediatrics: The Role of Lipid Partitioning. Ann Pediatr Child Health 2014; 2(1): 1007
(check this in PDF content)
31
Siew ED, Ikizler TA. Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease. Contrib Nephrol 2008; 161:138–144
(check this in PDF content)
32
Hien Phama, Kristina M. Utzschneiderb and Ian H. de Boera Measurement of insulin resistance in chronic kidney disease. Current Opinion in Nephrology and Hypertension 2011; 20:640–646
(check this in PDF content)
33
Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005; 365:1333–1346
(check this in PDF content)
34
Raalte DH, Brands M, van der Zijl NJ, et al. Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial. Diabetologia Aug 2011; 54(8):2103-2112
(check this in PDF content)
35
George Bayliss, Larry A. Weinrauch, John A. D’Elia Pathophysiology of Obesity-related renal Dysfunction Contributed to Diabetic nephropathy. Curr Diab Rep DOI 10. 1007/s11892-0120288-1
(check this in PDF content)
36
Paula FJA, Rosen CJ. Bone remodeling and Energy metabolism: New perspectives. Bone research 2013; 1(1): 72-84. doi: 10.4248/BR201301005
(check this in PDF content)
37
Tai K, Need AG, Horowitz M, Chapman IM. Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition 2008; 24(3): 279–285
(check this in PDF content)
38
Дудинская ЕН, Ткачева ОН. Роль витамина Д в развитии артериальной гипертензии. Кардиоваскулярная терапия и профилактика 2012; 11(3): 77-81 [Dudinskaia EN, Tkacheva ON. Rol` vitamina D v razvitii arterial`noi` gipertenzii. Kardiovaskuliarnaia terapiia i profilaktika 2012; 11(3): 77-81]
(check this in PDF content)
39
Karolina DS, Silambarasan M, Armugam A, Yeyaseelan K. MicroRNAs and Endothelial Dysfunction in Relation to Obesity and Type2 Diabetes J Mol Genet med. S1: 011.doi:10.4172/17470862.S1-011)
(check this in PDF content)
40
Ranganath Muniyappa, James R. Sowers Role of insulin resistance in endothelial dysfunction. Reviews in Endocrine and Metabolic Disorders 2013; 14 (1): 5-12
(check this in PDF content)
41
Rabkin R, Ryan MP, Duckworth WC. The renal metabolism of insulin. Diabetologia 1984; 27 ( 3): 351–357
(check this in PDF content)
42
Shoko Horita, George Seki, Hideomi Yamada et al. Insulin Resistance, Obesity, Hypertension, and Renal Sodium Transport. International Journal of Hypertension 2011; Article ID 391762, 8 pages http:// dx.doi.org/10.4061/2011/391762
(check this in PDF content)
43
Tsimaratos M, Roger F, Chabardès D et al. C-peptide stimulates Na+,K+-ATPase activity via PKC alpha in rat medullary thick ascending limb. Diabetologia 2003; 46 (1): 124–131
(check this in PDF content)
44
DeFronzo RA, Cooke CR, Andres R. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. Journal of Clinical Investigation 1975; 55 (4): 845–855
(check this in PDF content)
45
Тюзиков ИА. Инсулинорезистентность как системный фактор патогенеза заболеваний почек. Сахарный диабет 2014; (1): 47-56 [Tiuzikov IA.Insulinorezistentnost` kak sistemny`i` faktor patogeneza zabolevanii` pochek. Saharny`i` diabet 2014; (1): 47-56]
(check this in PDF content)
46
Simpkin A, Cochran E, Cameron F et al. Insulin receptor and the kidney: nephrocalcinosis in Patients with Recessive INSR Mutations. Nephron Physiology 2014;128: 55-61 DOI: 10.1159/000366225
(check this in PDF content)
47
Becker B, Kronenberg F, Kielstein J et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005; 16: 1091-1098
(check this in PDF content)
48
Kaartinen K, Syrjanen J, Porsti I et al. Insulin resistance and the Progression of IgA glomerulonephritis. Nephrol Dial Transplant 2006; 12: 1-6
(check this in PDF content)
49
Леванковская ЕИ, Швецов МЮ, Зилов АВ, Шилов ЕМ. Инсулинорезистентность как ранний предиктор неблагоприятного течения хронической болезни почек недиабетической этиологии. Нефрология и диализ 2010; 12(2): 74-81 [Levankovskaia EI, Shvetcov MIu, Zilov AV, Shilov EM. Insulinorezistentnost` kak rannii` prediktor neblagopriiatnogo techeniia khronicheskoi` bolezni pochek nediabeticheskoi` e`tiologii. Nefrologiia i dializ.2010; 12(2): 74-81]
(check this in PDF content)
50
Казакова ИА. Клинико-патогенетические механизмы прогрессирования хронического гломерулонефрита при формировании хронической почечной недостаточности. Автореф. дис. ... д-ра мед.наук. Пермь, 2005 [Kazakova IA. Clinikopatogeneticheskie mehanizmy` progressirovaniia khronicheskogo glomerulonefrita pri formirovanii khronicheskoi` pochechnoi` nedostatochnosti. Avtoreferat dis .d.m.n. Perm`, 2005]
(check this in PDF content)
51
Chen J, Muntner P, Hamm L et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephron 2003; 14: 469-477
(check this in PDF content)
52
Sechi L, Catena C, Zingaro L et al. Abnormalities of glucose metabolism in patients with early renal failure. Diabetes 2002; Vol. 51: 1226-1232
(check this in PDF content)
53
Jiaping Jin, Bo Jin, Songming Huang et al. Insulin resistance in children with primary nephrotic syndrome and normal renal function. Pediatr Nephrol 2012; 27 (10):1901-1909 Сведения об авторах: Проф. Смирнова Наталия Николаевна, д.м.н.
(check this in PDF content)